THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) issued statement with respect to media inquiries concerning Third Point LLC's equity position in the company. The company noted that it maintains an active, engaged dialogue with all shareholders. It has always appreciated the perspectives of all of its shareholders, including Third Point, and welcomes constructive input toward its common goal of enhancing shareholder value.
Amgen's Board frequently receives input from shareholders, including ideas like those offered by Third Point. The Board and management continually assess Amgen's strategic priorities - and, when appropriate, take action - to set the best path forward to increase shareholder value, Amgen said.
Amgen stated that it remains focused on addressing significant unmet medical needs for serious illnesses and driving value for all shareholders. It looks forward to further updating its shareholders on Amgen's strategic priorities and update on its restructuring plans at our business review on October 28th.
Earlier today, Daniel Loeb said his Third Point LLC has taken a stake in Amgen and urged Amgen to split into two separate businesses.
Copyright RTT News/dpa-AFX